Free tool
Cell therapy stocks
We cover 1 company grouped under the Cell therapy theme. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from +9.9% to +9.9% across the middle 80 percent of the group, with a median of +9.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 86 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| DTSQU | DT Cloud Star Acquisition Corporation | — | Small cap | +9.95% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.